Tiefenbacher Group manufacturing sites have been successfully registered by the United Arab Emirates Ministry of Health

The Tiefenbacher Group is very excited to announce that our two manufacturing sites at AET Laboratories in Hyderabad (India) and at Delorbis in Lefkosia (Cyprus) have been successfully registered by the United Arab Emirates Ministry of Health!

The United Arab Emirates (UAE) comprises seven Emirates located in the south east of the Arabian Peninsula: Abu Dhabi, Dubai, Sharjah, Ajman, Ras Al Khaimah, Umm al-Qaiwain and Fujairah. The approvals are based on our existing European and international certifications. The registration is a great door opener for the full region.

Furthermore it is an important addition to our existing European and international certifications (like the US FDA approval) and that follows Tiefenbacher Group´s strategy to make our high-quality pharmaceuticals better available worldwide!

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com